BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,000 | -46.2% | 3,057 | +60.3% | 0.00% | – |
Q2 2023 | $13,000 | -55.2% | 1,907 | +18.6% | 0.00% | – |
Q1 2023 | $29,000 | -49.1% | 1,608 | -40.5% | 0.00% | – |
Q4 2022 | $57,000 | +533.3% | 2,702 | +259.3% | 0.00% | – |
Q3 2022 | $9,000 | 0.0% | 752 | +10.1% | 0.00% | – |
Q2 2022 | $9,000 | -59.1% | 683 | -36.8% | 0.00% | – |
Q1 2022 | $22,000 | -71.1% | 1,081 | -71.2% | 0.00% | – |
Q4 2021 | $76,000 | -62.4% | 3,758 | -43.4% | 0.00% | – |
Q3 2021 | $202,000 | +16.1% | 6,644 | +10.9% | 0.00% | – |
Q2 2021 | $174,000 | -45.6% | 5,991 | -19.1% | 0.00% | – |
Q1 2021 | $320,000 | +20.8% | 7,406 | +29.2% | 0.00% | – |
Q4 2020 | $265,000 | +113.7% | 5,734 | +100.3% | 0.00% | – |
Q3 2020 | $124,000 | +85.1% | 2,862 | +126.8% | 0.00% | – |
Q2 2020 | $67,000 | +6600.0% | 1,262 | +2978.0% | 0.00% | – |
Q1 2020 | $1,000 | -83.3% | 41 | -90.0% | 0.00% | – |
Q4 2019 | $6,000 | – | 412 | +20500.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 2 | -97.8% | 0.00% | – |
Q2 2019 | $1,000 | – | 91 | +600.0% | 0.00% | – |
Q3 2018 | $0 | -100.0% | 13 | -99.5% | 0.00% | – |
Q1 2018 | $25,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |